| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-1.24 |
| Equity |
99.64 |
| Trep |
1.60 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
40.88% |
| Top 10 Holdings |
62.05% |
| Top 25 Holdings |
93.94% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
61.13 |
| Healthcare |
38.51 |
| Cash |
0.36 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.80 |
| PE Ratio |
44.03 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
14.52 |
| Fortis Health Care Ltd |
8.04 |
| Lupin Limited |
7.75 |
| Laurus Labs Limited |
5.67 |
| Glenmark Pharmaceuticals Limited |
4.90 |
| Aurobindo Pharma Limited |
4.86 |
| Alkem Laboratories Limited |
4.81 |
| MANKIND PHARMA LIMITED |
4.72 |
| Biocon Limited |
3.53 |
| IPCA Laboratories Limited |
3.25 |
| Krishna Inst of Medical Sciences Ltd. |
3.01 |
| Abbott India Limited |
2.65 |
| Gland Pharma Limited |
2.51 |
| J B Chemicals and Pharma Ltd |
2.36 |
| Aster DM Healthcare Limited |
2.29 |
| Dr Lal Path Labs Ltd |
2.08 |
| Narayana Hrudalaya Ltd |
2.01 |
| Syngene International Limited |
2.01 |
| EQ- GLOBAL HEALTH LTD. |
1.95 |
| Glaxosmithkline Pharma Ltd |
1.94 |
| Piramal Pharma Limited |
1.92 |
| Neuland Laboratories Limited |
1.90 |
| Cohance Lifesciences Limited |
1.90 |
| Ajanta Pharma Limited |
1.76 |
| Collateralized Borrowing & Lending Obligation |
1.60 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
